Are noninferiority studies ethically inferior?

American Journal of Health-System Pharmacy

Volumn 75, Issue 12, 2018, Pages 911-914

  Graber, Mark A ^a   Ely, John ^a   Faine, Brett A ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Clinical trials; Ethics; Noninferiority

Indexed keywords

ALTERNATIVE HYPOTHESIS; BENEFICENCE; DRUG INDUSTRY; EQUIPOISE; EXPERIMENTAL THERAPY; HUMAN; NOTE; NULL HYPOTHESIS; PRIORITY JOURNAL; EQUIVALENCE TRIAL (TOPIC); MEDICAL ETHICS; METHODOLOGY; STANDARDS; TREATMENT OUTCOME;

DRUG;

EQUIVALENCE TRIALS AS TOPIC; ETHICS, PHARMACY; HUMANS; PHARMACEUTICAL PREPARATIONS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 85048195413     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp170437     Document Type: Note

References (22)

1. Gomberg-Maitland M, Frison L, Halperin JL. Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality. Am Heart J. 2003; 146:398-403.
2. Pocock SJ The pros and cons of noninferiority trials. Fundam Clin Pharmacol. 2003; 17:483-90.
3. Powers JH Noninferiority and equivalence trials: deciphering 'similarity' of medical interventions. Stat Med. 2008; 27:343-52.
4. The Belmont report: ethical principles and guidelines for the protection of human subjects of research (April 18, 1979). www.hhs.gov/ohrp/sites/default/files/the-belmont-report-508c-FINAL.pdf (accessed 2018 Mar 6).
5. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013; 310:2191-4.
6. Resnik DB Eliminating the daily life risks standard from the definition of minimal risk. J Med Ethics. 2005; 31:35-8.
7. Eyal N. Informed consent, the value of trust, and hedons. J Med Ethics. 2014; 40:447-8.
8. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987; 317:141-5.
9. Chopra V, Davis M. In search of equipoise. JAMA. 2011; 305:1234-5.
10. Wendler D. The ethics of clinical research. https://plato.stanford.edu/entries/clinical-research/research/ (accessed 2018 Mar 6).
11. Miller FG, Joffe S. Equipoise and the dilemma of randomized clinical trials. N Engl J Med. 2011; 364:476-80.
12. Schumi J, Wittes JT. Through the looking glass: understanding non-inferiority. Trials. 2011; 12:106.
13. Kaul S, Diamond GA. Good enough: a primer on the analysis and interpretation of noninferiority trials. Ann Intern Med. 2006; 145:62-9.
14. Food and Drug Administration. Non-inferiority clinical trials to establish effectiveness: guidance for industry (November 2016). www.fda.gov/downloads/Drugs/Guidances/UCM202140.pdf (accessed 2018 Mar 6).
15. Wangge G, Klungel OH, Roes KC et al. Room for improvement in conducting and reporting non-inferiority randomized controlled trials on drugs: a systematic review. PLoS One. 2010; 5:e13550.
16. Rehal S, Morris T P, Fielding K et al. Non-inferiority trials: are they inferior? A systematic review of reporting in major medical journals. BMJ Open. 2016; 6:e012594.
17. Piaggio G, Elbourne DR, Pocock SJ et al. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA. 2012; 308:2594-604.
18. James PA, Oparil S, Carter BL et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311:507-20.
19. Miller FG, Brody H. Clinical equipoise and the incoherence of research ethics. J Med Philos. 2007; 32:151-65.
20. Djulbegovic B, Kumar A, Glasziou PP et al. New treatments compared to established treatments in randomized trials. Cochrane Database Syst Rev. 2012; 10: MR000024.
21. Reverby SM Ethical failures and history lessons: the U.S. Public Health Service research studies in Tuskegee and Guatemala. Pub Health Rev. 2012; 34:1-18.
22. Jorgensen KJ, Johansen HK, Gotzsche PC. Flaws in design, analysis and interpretation of Pfizer's antifungal trials of voriconazole and uncritical subsequent quotations. Trials. 2006; 7:3.